Latest News about PTGX
Recent news which mentions PTGX
From Benzinga
From Benzinga
Top 5 Health Care Stocks That Are Ticking Portfolio Bombs
March 14, 2023
From Benzinga
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 07, 2023
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 07, 2023
From Benzinga
Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday
March 07, 2023
From Benzinga
Why Protagonist Therapeutics Shares Are Trading Higher Today
March 07, 2023
From Benzinga
Top 5 Health Care Stocks That May Collapse In February
February 13, 2023
From Benzinga
From Benzinga
3 Biotech Stocks to Buy Before They Boom
June 01, 2022
From InvestorPlace
A new generation of ulcerative colitis drugs is in development. Will they be the blockbusters that pharma wants?
May 26, 2022
From MarketWatch
From Benzinga
From Benzinga
From InvestorPlace
71 Biggest Movers From Yesterday
April 27, 2022
From Benzinga
Mid-Afternoon Market Update: Crude Oil Rises Over 3%; Protagonist Therapeutics Shares Plummet
April 26, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 26, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 26, 2022
From Benzinga
From Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
April 26, 2022
From Benzinga
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 26, 2022
From Benzinga
18 Stocks Moving in Tuesday's Pre-Market Session
April 26, 2022
From Benzinga
Protagonist Therapeutics Topline Data from Phase 2 IDEAL Study of PN-943 (450 mg BID) Miss Primary Endpoint
April 25, 2022
Tickers
PTGX
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.